Sixth BHD Symposium and First International Upstate Kidney Cancer Symposium: latest scientific and clinical discoveries

Gennady Bratslavsky; Mark R Woodford; Michael Daneshvar; Mehdi Mollapour

doi:10.18632/oncotarget.7733

Sixth BHD Symposium and First International Upstate Kidney Cancer Symposium: latest scientific and clinical discoveries

Oncotarget. 2016 Mar 29;7(13):15292-8. doi: 10.18632/oncotarget.7733.

Authors

Gennady Bratslavsky^{1

2}, Mark R Woodford^{1

2

3}, Michael Daneshvar^{1

2}, Mehdi Mollapour^{1

2

3}

Affiliations

¹ Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
² Cancer Research Institute, SUNY Upstate Medical University, Syracuse, NY, USA.
³ Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, USA.

Abstract

The Sixth BHD Symposium and First International Upstate Kidney Cancer Symposium concluded in September 2015, in Syracuse, NY, USA. The program highlighted recent findings in a variety of areas, including drug development, therapeutics and surgical management of patients with BHD and multi-focal renal tumors, as well as multidisciplinary approaches for patients with localized, locally advanced and metastatic renal cell carcinoma.

Keywords: Birt-Hogg-Dubé syndrome; FLCN; clear cell renal cell carcinoma; renal cell carcinoma.

Publication types

Congress

MeSH terms

Humans
Kidney Neoplasms*